If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECHO.L Regulatory News (ECHO)

  • There is currently no data for ECHO

Successful Loan Restructuring

1 Oct 2021 07:00

RNS Number : 6481N
Echo Energy PLC
01 October 2021
 

1 October 2021

 

Echo Energy plc

("Echo" or the "Company")

 

Successful Loan Restructuring

 

Echo Energy, the Latin American focused upstream oil and gas company, is pleased to announce that it has successfully agreed the restructuring of the Company's £1.0 million loan originally provided to the Company in March 2017 and now held by Spartan Class O (the "Lender"), a sub-fund of Spartan Fund Limited SAC (the "Loan") with the Lender.

The terms of the amendment to the Loan (the "Amendment") are as follows:

 

· Maturity extended by 2 years such that the then outstanding remaining principal and accumulated accrued interest will mature on 8 March 2024 ("Maturity") following four quarterly cash prepayments of £25,000 commencing on 31 March 2023.

 

· Interest reduction such that all Loan interest will be accrued and paid on Maturity at a reduced rate of 8% per annum from Amendment (previously 12% per annum) on outstanding principal on a non-compounding basis.

 

· 15% of the remaining £850,000 Loan principal, representing £127,500, has now been converted into 10,200,000 new Echo ordinary shares (the "Conversion Shares") at an effective issue price of 1.25p - a premium of 108% to the closing mid market price per Echo ordinary share on 30 September 2021.

 

· Conversion Shares to be locked-in for a period of 6 months from Admission (as defined below).

 

Prior to the Amendment the full Loan, together with interest, had been due to mature on 8 March 2022 - with quarterly cash repayments of £50,000 prior to that maturity date.

 

In connection with the Amendment, the Lender has been issued with 3,096,429 warrants to subscribe for new ordinary shares in the Company at a price of 0.7 pence per new ordinary share, exercisable from the date of grant and with an expiry date of 30 September 2022.

 

Application has been made for the Conversion Shares, which rank pari passu with the Company's existing ordinary shares, to be admitted to trading on AIM. It is expected that admission of the Conversion Shares, will occur at 8.00 a.m. on 7 October ("Admission").

 

Following Admission, the Company's issued ordinary share capital will comprise 1,309,013,085 Ordinary Shares, none of which are held in treasury. Therefore, following Admission, the total number of ordinary shares with voting rights in the Company will be 1,309,013,085 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Martin Hull, Chief Executive Officer of Echo Energy, commented:

 

"The successful restructuring of the loan represents an important and positive step for the business as we continue to make great progress in 2021 both commercially and operationally. It materially reduces the near term cash outflow by delaying maturity whilst additionally reducing ongoing debt servicing costs, further strengthening our financial platform. These steps free additional resources to support our ongoing strategy of reinvestment in rapid payback production growth opportunities at a time of commodity price strength, reinforced by our attractively priced gas contracts. By investing in Echo at a more than 100% premium to the prevailing share price and agreeing to the lock up period, not only are the Lenders strengthening the balance sheet but also demonstrating confidence in the business and its strategy."

 

 

For further information, please contact:

 

Echo Energy

Martin Hull, Chief Executive Officer

 

via Vigo Communications

Vigo Consulting (IR & PR Advisor)

Patrick d'Ancona

Chris McMahon

 

+44 (0) 20 7390 0230

Cenkos Securities (Nominated Adviser)

Ben Jeynes

Katy Birkin

 

+44 (0) 20 7397 8900

Shore Capital (Corporate Broker)

Jerry Keen

+44 (0) 20 7408 4090

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFEIAFIIVIL
Date   Source Headline
9th May 20237:00 amRNSProposed Partial Sale of Santa Cruz Sur Assets
24th Apr 20233:19 pmRNSHolding(s) in Company
21st Apr 20232:42 pmRNSHolding(s) in Company
20th Apr 20233:09 pmRNSHolding(s) in Company
19th Apr 20232:22 pmRNSHolding(s) in Company
18th Apr 20237:00 amRNSQ1 2023 Production, Commercial & Corporate Update
17th Apr 20231:35 pmRNSHolding(s) in Company
21st Mar 20235:14 pmRNSHolding(s) in Company
9th Mar 20234:05 pmRNSHolding(s) in Company
3rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Feb 20232:33 pmRNSHolding(s) in Company
3rd Feb 20234:43 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSCommercial and Financial Update
1st Feb 202310:37 amRNSChange of Adviser
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 20237:00 amRNSQ4 2022 Production Update & Directorate Change
23rd Dec 20227:01 amRNSIntended Non-Executive Director Appointment
23rd Dec 20227:00 amRNSExercise of Warrants and Total Voting Rights
19th Dec 20223:06 pmRNSHolding(s) in Company
15th Dec 20226:05 pmRNSHolding(s) in Company
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
12th Dec 20222:42 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSOperations Update: Chorillos Well Reactivation
2nd Dec 20227:00 amRNSDebt Restructuring Completion & Issue of Equity
10th Nov 20227:00 amRNSOperations Update: Production Enhancement Plan
24th Oct 20222:59 pmRNSResult of General Meeting
20th Oct 20224:16 pmRNSBlock Admission Update
14th Oct 20225:23 pmRNSHolding(s) in Company
13th Oct 202211:27 amRNSResult of Bondholder Meeting & Directorate Change
11th Oct 20227:00 amRNSQ3 2022 Production and Operational Update
7th Oct 20225:01 pmRNSNotice of General Meeting
30th Sep 20227:00 amRNSHalf-year Report
29th Sep 20225:32 pmRNSResults of General Meeting
28th Sep 202211:12 amRNSAdjourned Noteholder Meeting
27th Sep 20227:00 amRNSOperations Update: Production Enhancement Plan
26th Sep 20228:43 amRNSHolding(s) in Company
6th Sep 20225:19 pmRNSPublication of Annual Report and Notice of GM
6th Sep 20227:00 amRNSFinal Results
5th Sep 20228:30 amRNSPublication of Bond Restructuring Proposals
1st Sep 20224:43 pmRNSTotal Voting Rights
1st Sep 202212:15 pmRNSHolding(s) in Company
30th Aug 20225:59 pmRNSHolding(s) in Company
30th Aug 20221:23 pmRNSExtension to publication of 2021 accounts
26th Aug 20227:00 amRNSProgress Update
15th Aug 20227:00 amRNSResult of Placing
12th Aug 20225:02 pmRNSProposed Debt Restructuring and Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.